PREVIEW
Although kidney transplantation is the treatment of choice for end-stage kidney disease, recipients require careful follow-up to prevent complications. In this article, Drs Andany and Kasiske review the major causes of allograft dysfunction in kidney transplant recipients, identify recipients' foremost risks of infection and malignancy, and outline the major cardiovascular disease risk factors involved with kidney transplantation. Potential drug interactions in transplant recipients are also discussed.